ISIN | CH0215804714 |
---|---|
Valor Number | 21580471 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund Large Caps Switzerland NT |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | Das Anlageziel der Teilvermögen des Umbrella-Fonds besteht hauptsächlich darin, einen angemessenen Anlageertrag in der Rechnungseinheit der einzelnen Teilvermögen mittels Investitionen in die nachstehend aufgeführten Anlagen zu erreichen. Das Teilvermögen bildet bis zum 17. September 2017 grundsätzlich den Referenzindex Swiss Market Index SMI® und ab dem 18. September 2017 den Referenzindex Swiss Performance Index® 20 (SPI® 20) nach. Dabei kann die Fondsleitung, statt in sämtliche Titel des Referenzindexes zu investieren, auf eine repräsentative Auswahl von Titeln zurückgreifen (Optimized Sampling). |
Peculiarities |
Current Price * | 175.52 CHF | 25.08.2025 |
---|---|---|
Previous Price * | 176.36 CHF | 22.08.2025 |
52 Week High * | 183.74 CHF | 03.03.2025 |
52 Week Low * | 153.86 CHF | 09.04.2025 |
NAV * | 175.52 CHF | 25.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,874,042,724 | |
Unit/Share Assets *** | 1,664,560,050 | |
Trading Information SIX |
YTD Performance | +8.41% |
31.12.2024 - 25.08.2025
31.12.2024 25.08.2025 |
---|---|---|
1 month | +2.09% |
25.07.2025 - 25.08.2025
25.07.2025 25.08.2025 |
3 months | -0.88% |
26.05.2025 - 25.08.2025
26.05.2025 25.08.2025 |
6 months | -3.44% |
25.02.2025 - 25.08.2025
25.02.2025 25.08.2025 |
1 year | +1.83% |
26.08.2024 - 25.08.2025
26.08.2024 25.08.2025 |
2 years | +16.99% |
25.08.2023 - 25.08.2025
25.08.2023 25.08.2025 |
3 years | +18.13% |
25.08.2022 - 25.08.2025
25.08.2022 25.08.2025 |
5 years | +32.86% |
25.08.2020 - 25.08.2025
25.08.2020 25.08.2025 |
Equity Participation Rate in % | 98.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 6.506 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 25.08.2025 |
Novartis AG Registered Shares | 14.98% | |
---|---|---|
Nestle SA | 14.83% | |
Roche Holding AG | 14.63% | |
UBS Group AG Registered Shares | 7.41% | |
ABB Ltd | 6.84% | |
Zurich Insurance Group AG | 6.60% | |
Compagnie Financiere Richemont SA Class A | 5.81% | |
Swiss Re AG | 3.49% | |
Lonza Group Ltd | 3.35% | |
Alcon Inc | 2.91% | |
Last data update | 31.07.2025 |
TER | 0.00% |
---|---|
TER date | 31.01.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |